Re-purposing Nonantimicrobial Therapeutics for Multidrug-resistant Pathogens; FDA Perspective

Speaker(s)

• 

  Dmitri Iarikov, MD, PhD

  Deputy Director, Division of Anti-Infectives
  FDA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.